抗CRISPRタンパク質によるCRISPR-Cas抑制の複数のメカニズム
Joseph Bondy-Denomy1, Bianca Garcia1, Scott Strum2
1Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Nature
|September 30, 2015
まとめ
バクテリオファージは抗CRISPRタンパク質を進化させて バクテリアのCRISPR-Cas免疫システムを無効にしています これらのファージは,CRISPR-Cas DNAの標的と機能をブロックするために異なるメカニズムを使用し,多様な進化的戦略を明らかにします.
科学分野:
- 微生物学
- 分子生物学
- ウイルス学
背景:
- バクテリアはファグ感染に対する適応免疫としてCRISPR-Casシステムを利用します.
- バクテリアを感染させる ウイルスであるファージは バクテリアの免疫を克服する 防御メカニズムを進化させます
研究 の 目的:
- バクテリアのCRISPR-Casシステムを阻害するファグでコードされた抗CRISPRタンパク質の作用メカニズムを調査する.
- CRISPR-Cas媒介による細菌防御を回避するためにファージが採用する多様な戦略を特徴付ける.
主な方法:
- タンパク質の相互作用と機能を研究する生化学的測定法
- 抗CRISPR活性を評価するための細菌システムにおける in vivo 実験
- DNA結合干渉と酵素募集阻害を含む明確な抑制メカニズムの分析
主要な成果:
- 独特の抑制メカニズムを持つ3つの異なる抗CRISPRタンパク質を特定し,特徴づけました.
- 2つのタンパク質は,異なるサブユニットとのステリックおよび非ステリック相互作用を通じてCRISPR- CasDNA結合を阻害する.
- 3つ目のタンパク質は,Cas3ヘリカーゼ-ニュクレアスを結合し,その採用を防止し,システムを転写抑制剤に変換します.
結論:
- ファージのアンチCRISPRタンパク質は,独立した進化を示唆する多様なメカニズムを示しています.
- これらの発見は,バイオテクノロジーに潜在的な影響を及ぼすCRISPR-Casの活性を調節する新しい方法を強調しています.
- 様々なアンチCRISPR戦略の発見は,CRISPR-Casの機能を変化させるためのさらなる特徴づけられていないメカニズムの存在を暗示しています.
関連する概念動画
CRISPR/Cas9 Genome Editing
526
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
526
The Antiviral System of Bacteria and Archaea: CRISPR
185
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
185
CRISPR and crRNAs
17.6K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.6K
CRISPR
53.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.3K
Caspases
12.8K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.8K
Homologous Recombination
54.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
54.7K


